Summary

The global market for Metabolomics Reagents was estimated to be worth US$ 26.18 million in 2023 and is forecast to a readjusted size of US$ 61.94 million by 2030 with a CAGR of 13.22% during the forecast period 2024-2030.
North American market for Metabolomics Reagents was valued at $ 10.10 million in 2023 and will reach $ 24.00 million by 2030, at a CAGR of 13.26% during the forecast period of 2024 through 2030.
Asia-Pacific market for Metabolomics Reagents was valued at $ 6.55 million in 2023 and will reach $ 16.22 million by 2030, at a CAGR of 13.97% during the forecast period of 2024 through 2030.
Europe market for Metabolomics Reagents was valued at $ 7.91 million in 2023 and will reach $ 18.18 million by 2030, at a CAGR of 12.77% during the forecast period of 2024 through 2030.

The global key companies of Metabolomics Reagents include Biocrates, Cambridge Isotope Laboratories, Metware Biotechnology, IROA Technologies and Beijing BGI-GBI Biotech Co., Ltd. (GBI) etc. In 2023, the global five largest players hold a share approximately 71.12% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Metabolomics Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolomics Reagents by region & country, by Type, and by Application.
The Metabolomics Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Reagents.

Market Segmentation

By Company
Biocrates
Cambridge Isotope Laboratories
Metware Biotechnology
IROA Technologies
Beijing BGI-GBI Biotech Co., Ltd. (GBI)
Fluidome
BIOTERE
Metabolomix

Segment by Type
Targeted Metabolomics
Untargeted Metabolomics

Segment by Application
Biological Companies
Research Institutions
Educational Institutions

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific

Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabolomics Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Metabolomics Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Metabolomics Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview 1
1.1 Metabolomics Reagents Product Introduction 1
1.2 Global Metabolomics Reagents Market Size Forecast (2019-2030) 1
1.3 Metabolomics Reagents Market Trends & Drivers 3
1.3.1 Metabolomics Reagents Industry Trends 3
1.3.2 Metabolomics Reagents Market Drivers & Opportunity 4
1.3.3 Metabolomics Reagents Market Challenges 5
1.3.4 Metabolomics Reagents Market Restraints 6
1.4 Assumptions and Limitations 6
1.5 Study Objectives 7
1.6 Years Considered 8
2 Competitive Analysis by Company 9
2.1 Global Metabolomics Reagents Players Revenue Ranking (2023) 9
2.2 Global Metabolomics Reagents Revenue by Company (2019-2024) 9
2.3 Key Companies Metabolomics Reagents Manufacturing Base Distribution and Headquarters 11
2.4 Key Companies Metabolomics Reagents Product Offered 11
2.5 Key Companies Time to Begin Mass Production of Metabolomics Reagents 12
2.6 Metabolomics Reagents Market Competitive Analysis 12
2.6.1 Metabolomics Reagents Market Concentration Rate (2019-2024) 12
2.6.2 Global 3 and 5 Largest Companies by Metabolomics Reagents Revenue in 2023 14
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Reagents as of 2023) 15
3 Segmentation by Type 17
3.1 Introduction by Type 17
3.1.1 Targeted Metabolomics 17
3.1.2 Untargeted Metabolomics 18
3.2 Global Metabolomics Reagents Sales Value by Type 18
3.2.1 Global Metabolomics Reagents Sales Value by Type (2019 VS 2023 VS 2030) 19
3.2.2 Global Metabolomics Reagents Sales Value, by Type (2019-2030) 20
3.2.3 Global Metabolomics Reagents Sales Value, by Type (%) (2019-2030) 21
4 Segmentation by Application 22
4.1 Introduction by Application 22
4.1.1 Biological Companies 22
4.1.2 Research Institutions 22
4.1.3 Educational Institutions 23
4.2 Global Metabolomics Reagents Sales Value by Application 23
4.2.1 Global Metabolomics Reagents Sales Value by Application (2019 VS 2023 VS 2030) 24
4.2.2 Global Metabolomics Reagents Sales Value, by Application (2019-2030) 25
4.2.3 Global Metabolomics Reagents Sales Value, by Application (%) (2019-2030) 26
5 Segmentation by Region 28
5.1 Global Metabolomics Reagents Sales Value by Region 28
5.1.1 Global Metabolomics Reagents Sales Value by Region: 2019 VS 2023 VS 2030 28
5.1.2 Global Metabolomics Reagents Sales Value by Region (2019-2024) 28
5.1.3 Global Metabolomics Reagents Sales Value by Region (2025-2030) 29
5.1.4 Global Metabolomics Reagents Sales Value by Region (%), (2019-2030) 29
5.2 North America 30
5.2.1 North America Metabolomics Reagents Sales Value, 2019-2030 30
5.2.2 North America Metabolomics Reagents Sales Value by Country (%), 2023 VS 2030 31
5.3 Europe 32
5.3.1 Europe Metabolomics Reagents Sales Value, 2019-2030 32
5.3.2 Europe Metabolomics Reagents Sales Value by Country (%), 2023 VS 2030 33
5.4 Asia Pacific 34
5.4.1 Asia Pacific Metabolomics Reagents Sales Value, 2019-2030 34
5.4.2 Asia Pacific Metabolomics Reagents Sales Value by Region (%), 2023 VS 2030 35
5.5 Latin America 36
5.5.1 Latin America Metabolomics Reagents Sales Value, 2019-2030 36
5.5.2 Latin America Metabolomics Reagents Sales Value by Country (%), 2023 VS 2030 37
5.6 Middle East & Africa 37
6 Segmentation by Key Countries/Regions 39
6.1 Key Countries/Regions Metabolomics Reagents Sales Value Growth Trends, 2019 VS 2023 VS 2030 39
6.2 Key Countries/Regions Metabolomics Reagents Sales Value, 2019-2030 40
6.3 United States 43
6.3.1 United States Metabolomics Reagents Sales Value, 2019-2030 43
6.3.2 United States Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030 44
6.3.3 United States Metabolomics Reagents Sales Value by Application, 2023 VS 2030 45
6.4 Europe 46
6.4.1 Europe Metabolomics Reagents Sales Value, 2019-2030 46
6.4.2 Europe Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030 47
6.4.3 Europe Metabolomics Reagents Sales Value by Application, 2023 VS 2030 48
6.5 China 49
6.5.1 China Metabolomics Reagents Sales Value, 2019-2030 49
6.5.2 China Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030 50
6.5.3 China Metabolomics Reagents Sales Value by Application, 2023 VS 2030 51
6.6 Japan 52
6.6.1 Japan Metabolomics Reagents Sales Value, 2019-2030 52
6.6.2 Japan Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030 53
6.6.3 Japan Metabolomics Reagents Sales Value by Application, 2023 VS 2030 54
6.7 South Korea 55
6.7.1 South Korea Metabolomics Reagents Sales Value, 2019-2030 55
6.7.2 South Korea Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030 56
6.7.3 South Korea Metabolomics Reagents Sales Value by Application, 2023 VS 2030 57
7 Company Profiles 58
7.1 Biocrates 58
7.1.1 Biocrates Profile 58
7.1.2 Biocrates Main Business 59
7.1.3 Biocrates Metabolomics Reagents Products, Services and Solutions 59
7.1.4 Biocrates Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 61
7.2 Cambridge Isotope Laboratories 61
7.2.1 Cambridge Isotope Laboratories Profile 62
7.2.2 Cambridge Isotope Laboratories Main Business 62
7.2.3 Cambridge Isotope Laboratories Metabolomics Reagents Products, Services and Solutions 63
7.2.4 Cambridge Isotope Laboratories Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 64
7.2.5 Cambridge Isotope Laboratories Recent Developments 65
7.3 Metware Biotechnology 65
7.3.1 Metware Biotechnology Profile 65
7.3.2 Metware Biotechnology Main Business 66
7.3.3 Metware Biotechnology Metabolomics Reagents Products, Services and Solutions 66
7.3.4 Metware Biotechnology Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 67
7.4 IROA Technologies 67
7.4.1 IROA Technologies Profile 68
7.4.2 IROA Technologies Main Business 68
7.4.3 IROA Technologies Metabolomics Reagents Products, Services and Solutions 69
7.4.4 IROA Technologies Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 69
7.5 Beijing BGI-GBI Biotech Co., Ltd. (GBI) 70
7.5.1 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Profile 70
7.5.2 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Main Business 70
7.5.3 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Products, Services and Solutions 71
7.5.4 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 72
7.6 Fluidome 72
7.6.1 Fluidome Profile 72
7.6.2 Fluidome Main Business 73
7.6.3 Fluidome Metabolomics Reagents Products, Services and Solutions 73
7.6.4 Fluidome Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 74
7.7 BIOTERE 75
7.7.1 BIOTERE Profile 75
7.7.2 BIOTERE Main Business 75
7.7.3 BIOTERE Metabolomics Reagents Products, Services and Solutions 76
7.7.4 BIOTERE Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 77
7.8 Metabolomix 77
7.8.1 Metabolomix Profile 77
7.8.2 Metabolomix Main Business 78
7.8.3 Metabolomix Metabolomics Reagents Products, Services and Solutions 78
7.8.4 Metabolomix Metabolomics Reagents Revenue (US$ Million) & (2019-2024) 79
8 Industry Chain Analysis 80
8.1 Metabolomics Reagents Industrial Chain 80
8.2 Metabolomics Reagents Raw Materials Analysis 80
8.2.1 Key Raw Materials 80
8.2.2 Manufacturing Cost Structure 82
8.3 Customers Analysis 82
8.4 Sales Model and Sales Channels 83
8.5 Metabolomics Reagents Distributors 84
9 Research Findings and Conclusion 85
10 Appendix 87
10.1 Research Methodology 87
10.1.1 Methodology/Research Approach 87
10.1.2 Data Source 90
10.2 Author Details 93
10.3 Disclaimer 94